...
首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice.
【24h】

Effect of selenium-containing compounds on hepatic chemoprotective enzymes in mice.

机译:含硒化合物对小鼠肝脏化学保护酶的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Selenite and organoselenium compounds have been examined at supranutritional levels for their ability to influence the activity and mRNA levels of chemoprotective enzymes in the livers of selenium-sufficient mice and the changes compared to those elicited by oltipraz. Compounds investigated included novel selenocysteine prodrugs that have previously been evaluated for their ability to reduce the tumorigenicity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in mice. Following seven daily doses (i.g.), all compounds except 2-methylselenazolidine-4(R)-carboxylic acid (MSCA) increased thioredoxin reductase activity (43-92%) but only for 2-oxoselenazolidine-4(R)-carboxylic acid (OSCA) was there an accompanying increase in mRNA. No compound enhanced glutathione peroxidase activity, although sodium selenite significantly elevated the mRNA of this enzyme. Oltipraz was an efficacious inducer of both thioredoxin reductase and glutathione peroxidase mRNAs. Sodium selenite, selenazolidine-4(R)-carboxylic acid (SCA), and OSCA elevated NAD(P)H-quinone oxidoreductase mRNA but only for OSCA was the elevation in mRNA accompanied by an increase in enzyme activity. L-Selenocystine significantly increased this activity without increasing mRNA levels. Sodium selenite, L-selenocystine, L-selenomethionine, and Se-methyl-L-selenocysteine all enhanced glutathione S-transferase activity. The increased activity with sodium selenite was accompanied by increases in mRNAs of Gst alpha, Gst mu and Gst pi classes, while for L-selenocystine and Se-methyl-L-selenocysteine, only an elevation in the mRNA for the Gst alpha class was observed. Gst alpha and Gst mu class mRNAs were elevated by OSCA without a significant elevation in enzyme activity. SCA and MSCA both elevated a Gst pi mRNA and MSCA elevated Gst mu in addition. By comparison, oltipraz only significantly elevated the mRNA of Gst mu, adding to the conclusion that across the entire study, no selenium compound appears to be acting purely through the antioxidant response typified by oltipraz. Despite their chemical similarity, the three cysteine prodrugs, SCA, MSCA, and OSCA, each produced its own unique pattern of effects on protective enzymes and none was identical to the pattern elicited by sodium selenite, L-selenocystine, L-selenomethionine, and Se-methyl-L-selenocysteine. The study also shows that after 7 days of administration, there was only occasional concordance between elevations in mRNA and enzyme activity for any selenium compound and for any protective enzyme, there was no response in common for all selenium compounds.
机译:已经在超营养水平上检测了亚硒酸盐和有机硒化合物影响硒充足小鼠肝脏化学保护酶活性和mRNA水平的能力,以及与oltipraz引起的变化相比,其变化。所研究的化合物包括新型硒代半胱氨酸前药,这些药物先前已被评估具有降低小鼠4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)致瘤性的能力。每天服用7剂(ig)后,除2-甲基硒代氮唑烷-4(R)-羧酸(MSCA)以外的所有化合物均提高了硫氧还蛋白还原酶的活性(43-92%),但仅对2-氧代硒唑烷-4(R)-羧酸( OSCA)mRNA随之增加。尽管亚硒酸钠显着提高了该酶的mRNA,但没有化合物能增强谷胱甘肽过氧化物酶的活性。 Oltipraz是硫氧还蛋白还原酶和谷胱甘肽过氧化物酶mRNA的有效诱导剂。亚硒酸钠,硒代唑烷-4(R)-羧酸(SCA)和OSCA升高了NAD(P)H-醌氧化还原酶mRNA的水平,但OSCA的唯一原因是mRNA的升高伴随着酶活性的增加。 L-硒代胱氨酸显着增加了这种活性,而没有增加mRNA水平。亚硒酸钠,L-硒代半胱氨酸,L-硒代蛋氨酸和Se-甲基-L-硒代半胱氨酸均增强了谷胱甘肽S-转移酶的活性。亚硒酸钠的活性增加伴随着Gst alpha,Gst mu和Gst pi类mRNA的增加,而对于L-硒代半胱氨酸和Se-甲基-L-硒代半胱氨酸,仅观察到Gst alpha类的mRNA升高。 。 OSCA升高了Gstα和Gstμ类mRNA,而酶活性没有明显升高。此外,SCA和MSCA均升高了Gst pi mRNA,而MSCA升高了Gst mu。相比之下,oltipraz仅显着提高Gst mu的mRNA,并得出结论,在整个研究中,似乎没有硒化合物仅通过oltipraz典型的抗氧化反应起作用。尽管它们的化学相似性,三种半胱氨酸前药SCA,MSCA和OSCA各自对保护酶产生了独特的作用模式,但均与亚硒酸钠,L-硒代半胱氨酸,L-硒代蛋氨酸和硒诱导的模式不同。 -甲基-L-硒代半胱氨酸。该研究还表明,给药7天后,任何硒化合物和任何保护性酶的mRNA和酶活性升高之间仅偶尔出现一致性,所有硒化合物均无共同反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号